OTCMKTS:SARTF Sartorius Q4 2024 Earnings Report $243.86 0.00 (0.00%) As of 09/24/2026 ProfileEarnings History Sartorius EPS ResultsActual EPS$1.11Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ASartorius Revenue ResultsActual Revenue$967.37 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ASartorius Announcement DetailsQuarterQ4 2024Date2/17/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsSartorius' next earnings date is estimated for Thursday, October 22, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Sartorius Earnings HeadlinesSartorius (OTCMKTS:SARTF) Stock Price Up 7.4% - What's Next?September 24 at 6:21 AM | americanbankingnews.comSartorius Stedim Biotech Updates Share Capital and Voting Rights StructureSeptember 3, 2026 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 25 at 1:00 AM | InvestorPlace (Ad)Sartorius Stedim Biotech Updates Market on Share Capital and Voting RightsAugust 4, 2026 | tipranks.comSartorius AG (SARTF) Q2 2026 Earnings Call Highlights: Strong Growth Amidst Market ChallengesJuly 23, 2026 | finance.yahoo.comSartorius Stedim Biotech Delivers H1 Growth and Confirms 2026 OutlookJuly 23, 2026 | tipranks.comSee More Sartorius Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sartorius? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sartorius and other key companies, straight to your email. Email Address About SartoriusSartorius (OTCMKTS:SARTF) AG is a Germany-based life science company that develops and supplies equipment, technologies and services for pharmaceutical, biotechnology and laboratory applications. Its offerings support the development, production and quality control of medicines, vaccines and other biological products. The company’s products include laboratory instruments, balances, filtration systems, laboratory consumables, bioreactors, cell-culture technologies, fluid-management systems, sensors and analytical equipment. Sartorius also provides single-use technologies and other solutions designed to help biopharmaceutical manufacturers improve production processes and maintain quality standards. Founded in 1870 by Florenz Sartorius in Göttingen, Germany, the company has expanded into an international supplier serving pharmaceutical and biotechnology companies, research institutions, universities and other laboratories. Sartorius operates across major life science markets in Europe, North America, Asia and other regions worldwide.View Sartorius ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
